| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 16983 | 2017 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 1921 | 2021 |
| Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 569 (7755), 260-264, 2019 | 716 | 2019 |
| Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study T Eslamparast, H Poustchi, F Zamani, M Sharafkhah, R Malekzadeh, ... The American journal of clinical nutrition 99 (3), 535-542, 2014 | 424 | 2014 |
| Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based … A Rodriguez-Martinez, B Zhou, MK Sophiea, J Bentham, CJ Paciorek, ... The Lancet 396 (10261), 1511-1524, 2020 | 349 | 2020 |
| Role of microbiota-derived short-chain fatty acids in nervous system disorders R Mirzaei, B Bouzari, SR Hosseini-Fard, M Mazaheri, Y Ahmadyousefi, ... Biomedicine & Pharmacotherapy 139, 111661, 2021 | 191 | 2021 |
| Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease M Mohamadnejad, G Montazeri, A Fazlollahi, F Zamani, J Nasiri, ... Official journal of the American College of Gastroenterology| ACG 101 (11 …, 2006 | 175 | 2006 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 130 | 2020 |
| Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease N Motamed, M Sohrabi, H Ajdarkosh, G Hemmasi, M Maadi, ... World journal of gastroenterology 22 (10), 3023, 2016 | 128 | 2016 |
| Conicity index and waist‐to‐hip ratio are superior obesity indices in predicting 10‐year cardiovascular risk among men and women N Motamed, D Perumal, F Zamani, H Ashrafi, M Haghjoo, FS Saeedian, ... Clinical cardiology 38 (9), 527-534, 2015 | 128 | 2015 |
| Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study T Eslamparast, F Zamani, A Hekmatdoost, M Sharafkhah, S Eghtesad, ... British journal of nutrition 112 (3), 438-445, 2014 | 126 | 2014 |
| Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B G Montazeri, A Estakhri, M Mohamadnejad, N Nouri, F Montazeri, ... BMC gastroenterology 5, 1-7, 2005 | 109 | 2005 |
| Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases N Motamed, B Rabiee, H Poustchi, B Dehestani, GR Hemasi, ... Clinics and research in hepatology and gastroenterology 41 (1), 31-38, 2017 | 107 | 2017 |
| Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis B Amirkalali, H Fakhrzadeh, F Sharifi, R Kelishadi, F Zamani, H Asayesh, ... Iranian red crescent medical journal 17 (12), 2015 | 107 | 2015 |
| Trace element and heavy metal levels in colorectal cancer: comparison between cancerous and non-cancerous tissues M Sohrabi, A Gholami, MHH Azar, M Yaghoobi, MM Shahi, S Shirmardi, ... Biological trace element research 183, 1-8, 2018 | 103 | 2018 |
| Effect of empagliflozin on liver steatosis and fibrosis in patients with non-alcoholic fatty liver disease without diabetes: a randomized, double-blind, placebo-controlled trial H Taheri, M Malek, F Ismail-Beigi, F Zamani, M Sohrabi, M Reza Babaei, ... Advances in therapy 37, 4697-4708, 2020 | 99 | 2020 |
| Empagliflozin improves liver steatosis and fibrosis in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled … H Chehrehgosha, MR Sohrabi, F Ismail-Beigi, M Malek, M Reza Babaei, ... Diabetes Therapy 12, 843-861, 2021 | 95 | 2021 |
| Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin F Zamani, M Mohamadnejad, R Shakeri, A Amiri, S Najafi, ... World Journal of Gastroenterology: WJG 14 (48), 7381, 2008 | 95 | 2008 |
| Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran B Amirkalali, H Poustchi, H Keyvani, MR Khansari, H Ajdarkosh, M Maadi, ... Iranian journal of public health 43 (9), 1275, 2014 | 94 | 2014 |
| The useage of opioids and their adverse effects in gastrointestinal practice: a review MR Khansari, MR Sohrabi, F Zamani Middle East journal of digestive diseases 5 (1), 5, 2013 | 93 | 2013 |
